TY - JOUR T1 - Prognostic Predictors After Surgical Intervention for Stage IV Gastric Cancer JF - Anticancer Research JO - Anticancer Res SP - 1541 LP - 1546 DO - 10.21873/anticanres.15627 VL - 42 IS - 3 AU - SATOSHI SUZUKI AU - NAOKI URAKAWA AU - HIROSHI HASEGAWA AU - SHINGO KANAJI AU - KIMIHIRO YAMASHITA AU - TAKERU MATSUDA AU - TARO OSHIKIRI AU - YOSHIHIRO KAKEJI Y1 - 2022/03/01 UR - http://ar.iiarjournals.org/content/42/3/1541.abstract N2 - Background/Aim: This study aimed to examine the efficacy of surgical intervention after chemotherapy for stage IV gastric cancer and the predictors of survival after surgical intervention. Patients and Methods: Forty-three gastric cancer patients who had only one type of incurable factor (e.g., para-aortic lymph node metastasis) and had undergone initial chemotherapy, underwent chemotherapy alone (CX group; n=25), palliative gastrectomy (PS group; n=8), and conversion surgery (CS group; n=10). Their therapeutic outcomes were compared. Results: The CS group had significantly higher 2-year overall survival rates (80%) than the CX group (25%), whose prognosis was similar to that of the PS group (23%; p<0.001). Pathological complete response of para-aortic lymph node or peritoneal metastases was an independent predictor of survival after surgery, as was >6 months of chemotherapy. Conclusion: CS may improve the prognosis of patients with stage IV gastric cancer in whom chemotherapy can achieve pathological disappearance of the metastatic lesions. ER -